Національний Медичний Університет Імені О.О. Богомольця
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Національний Медичний Університет Імені О.О. БогомольцяfiledCriticalНаціональний Медичний Університет Імені О.О. Богомольця
Priority to UAU201501112UpriorityCriticalpatent/UA99924U/en
Publication of UA99924UpublicationCriticalpatent/UA99924U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Coloring Foods And Improving Nutritive Qualities
(AREA)
Abstract
A method of treating diabetic retinopathy in patients with combined endocrine disorders involves the use of drugs. At all stages of treatment prescribed vitamin D3 in a dose of 2000-3000 IU / day for nonproliferative diabetic retinopathy stage, the proliferative stage - a dose of 3000-4000 IU / day for 2 months (except summer). Three months later, repeat the intake of vitamin D3 in the same dose.
UAU201501112U2015-02-112015-02-11A method of treating diabetic retinopathy in patients with combined endocrine disorders
UA99924U
(en)
methods and compositions using 4-amino-2- (2,6-dioxo-piperidin-3-yl) -isoindoline-1,3-dione for treatment and management of central nervous system cancers